Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.60 |
| ▸ | CA2 | P00918 | 11/20 | 0.59 |
| ▸ | CA1 | P00915 | 8/20 | 0.59 |
| ▸ | CA9 | Q16790 | 8/20 | 0.59 |
| ▸ | CA12 | O43570 | 6/20 | 0.59 |
| ▸ | CA7 | P43166 | 4/20 | 0.59 |
| ▸ | CA4 | P22748 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.55 |
| ▸ | MEN1 | O00255 | 3/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | RECQL | P46063 | 1/20 | 0.54 |
| ▸ | GFER | P55789 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | CNR2 | P34972 | 3/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8666349 | 0.89 | CA12 (0.68) | ALDH1A1CA2CA1CA9CA12 | |
| SCHEMBL15124998 | 0.89 | CA12 (0.68) | ALDH1A1CA2CA1CA9CA12 | |
| SCHEMBL414561 | 0.84 | CA2 (0.56) | ALDH1A1CA2CA1CA9CA12 | |
| SCHEMBL6313828 | 0.83 | ALDH1A1 (0.58) | ALDH1A1L3MBTL1MEN1KMT2AMAPT | |
| SCHEMBL28417720 | 0.82 | CA2 (0.62) | CA2CA1CA9CA12CA7 | |
| SCHEMBL3229040 | 0.79 | ALDH1A1 (0.65) | ALDH1A1L3MBTL1MEN1KMT2AMAPT | |
| SCHEMBL3223255 | 0.79 | ALDH1A1 (0.55) | ALDH1A1L3MBTL1MEN1KMT2AMAPT | |
| Methanesulfonamide SCHEMBL10655700 | 0.78 | ALDH1A1 (0.76) | ALDH1A1L3MBTL1MEN1KMT2AMAPT | |
| Benzenesulfonamide SCHEMBL9749746 | 0.77 | HSD11B1 (0.54) | ALDH1A1CA2CA1CA9CA12 | |
| SCHEMBL18995911 | 0.77 | CA2 (0.49) | CA2CA1CA9CA12CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115960081-A | Endoplasmic reticulum targeted glutathione fluorescent probe and preparation method thereof | 青岛科技大学 | 2023-04-14 | — | — | CN | claimed |
| CN-115960081-A | Endoplasmic reticulum targeted glutathione fluorescent probe and preparation method thereof | 青岛科技大学 | 2023-04-14 | — | — | CN | disclosed |
| US-7635662-B2 | Compound for color-producing composition, and recording material | CHEMIPRO KASEI KAISHA, LTD. (JP) | 2009-12-22 | — | — | US | disclosed |
| US-20010044553-A1 | Novel compound for color-producing composition, and recording material | CHEMIPRO KASEI KAISHA, LTD. (JP) | 2001-11-22 | — | — | US | disclosed |
| US-5565494-A | BENZENESULFONYLUREA DERIVATIVES | ELI LILLY AND COMPANY (US) | 1996-10-15 | — | — | US | disclosed |
| EP-0602878-A1 | Diarylsulfonylureas and their use as antitumor agents | ELI LILLY AND COMPANY (US) | 1994-06-22 | — | — | EP | disclosed |
| US-4515963-A | AMIDATIUON OF NAPHTHOLACTONE | CIBA GEIGY AG (CH) | 1985-05-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010044553-A1 | Novel compound for color-producing composition, and recording material | UROD, UMPS, UGT1A10 | ALDH1A1 99/4885CA2 1209/4885CA1 110/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.